Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety

Summary

Diabetes is the most frequently occurring chronic disease along with obesity, hypertension, and hyperlipidemia. The number of patients with diabetes is increasing worldwide. Despite rapid progress in management of diabetes, the problem is that glycemic target goal is still low showing 30-40%. Thus, diabetes has become a serious social, economic, and public health problem beyond individual health problems due to its increasing prevalence.

Timeline

Start

2022-01-01

Primary completion

2023-10-30

Completion

2023-12-31

Drugs

Indications